Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study

被引:40
作者
Eschwege, P. [1 ,2 ]
Moutereau, S.
Droupy, S. [1 ]
Douard, R. [3 ]
Gala, J-L [4 ]
Benoit, G.
Conti, M.
Manivet, P. [5 ]
Loric, S.
机构
[1] Bicetre Univ Hosp, Dept Urol, Le Kremlin Bicetre, France
[2] Antony Private Hosp, Urol Unit, Antony, France
[3] Cochin Univ Hosp, Dept Gen Surg, APHP, Paris, France
[4] St Luc Univ Hosp, Appl Mol Technol Ctr Human Genet, Brussels, Belgium
[5] Lariboisiere Univ Hosp, Lab Clin Biochem & Mol Biol, APHP, Paris, France
关键词
prostatic neoplasms; neoplasm circulating cells; retropubic prostatectomy; surgery prognosis; TUMOR-CELLS; HEMATOGENOUS DISSEMINATION; RADICAL PROSTATECTOMY; EPITHELIAL-CELLS; SURGERY; QUANTIFICATION; RESECTION; SURVIVAL;
D O I
10.1038/sj.bjc.6604912
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In clinically organ-confined prostate cancer patients, bloodstream tumour cell dissemination generally occurs, and may be enhanced by surgical prostate manipulation. To evaluate cancer-cell seeding impact upon patient recurrence-free survival, 155 patients were prospectively enrolled then followed. Here, 57 patients presented blood prostate cell shedding preoperatively and intraoperatively (group I). Of the 98 preoperatively negative patients, 53 (54%) remained negative (group II) and 45 (46%) became intraoperatively positive (group III). Median biological and clinical recurrence-free time was far shorter in group I (36.2 months, P<0.0001) than in group II (69.6 months) but did not significantly differ in group II and III (69.6 months vs 65.0). Such 5-year follow-up data show that preoperative circulating prostate cells are an independent prognosis factor of recurrence. Moreover, tumour handling induces cancer-cell seeding but surgical blood dissemination does not accelerate cancer evolution.
引用
收藏
页码:608 / 610
页数:3
相关论文
共 14 条
[1]   Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery [J].
Birbeck, KF ;
Macklin, CP ;
Tiffin, NJ ;
Parsons, W ;
Dixon, MF ;
Mapstone, NP ;
Abbott, CR ;
Scott, N ;
Finan, PJ ;
Johnston, D ;
Quirke, P .
ANNALS OF SURGERY, 2002, 235 (04) :449-457
[2]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[3]   HEMATOGENOUS DISSEMINATION OF PROSTATIC EPITHELIAL-CELLS DURING RADICAL PROSTATECTOMY [J].
ESCHWEGE, P ;
DUMAS, F ;
BLANCHET, P ;
LEMAIRE, V ;
BENOIT, G ;
JARDIN, A ;
LACOUR, B ;
LORIC, S .
LANCET, 1995, 346 (8989) :1528-1530
[4]   Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription-polymerase chain reaction [J].
Lintula, S ;
Vesalainen, S ;
Rannikko, A ;
Zhang, WM ;
Finne, P ;
Stenman, J ;
Stenman, UH .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2004, 64 (02) :93-100
[5]  
MAREEL MM, 1993, CRIT REV ONCOGENESIS, V4, P559
[6]   Circulating tumor cells predict survival in patients with metastatic prostate cancer [J].
Moreno, JG ;
Miller, MC ;
Gross, S ;
Allard, WJ ;
Gomella, LG ;
Terstappen, LWMM .
UROLOGY, 2005, 65 (04) :713-718
[7]   Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer [J].
Okegawa, Takatsugu ;
Nutahara, Kikuo ;
Higashihara, Eiji .
JOURNAL OF UROLOGY, 2008, 180 (04) :1342-1347
[8]   Blood dissemination of colonic epithelial cells during no-touch surgery for rectosigmoid cancer [J].
Sales, JP ;
Wind, P ;
Douard, R ;
Cugnenc, P ;
Loric, S .
LANCET, 1999, 354 (9176) :392-392
[9]   Prognostic value of circulating prostate cells in patients with a rising PSA after radical prostatectomy [J].
Tombal, B ;
Van Cangh, PJ ;
Loric, S ;
Gala, JL .
PROSTATE, 2003, 56 (03) :163-170
[10]  
Weitz J, 1998, CLIN CANCER RES, V4, P343